# A vertically integrated system for tracking and assessing cell-cycle-aware phenotypes under confinement

**Authors:** Melissa Pezzotti, Eloisa Torchia, Julius Zimmermann, Sara Rigolli, Alessandro Enrico, Martina Sarchi, Moises Di Sante, Francesco S. Pasqualini

PMC · DOI: 10.1063/5.0306480 · APL Bioengineering · 2026-03-04

## TL;DR

This paper introduces a new system to study how cell migration and cell cycle interact under spatial constraints, revealing changes in cell behavior and cycle progression.

## Contribution

The novel contribution is a vertically integrated platform combining fluorescent reporters, photopatterned matrices, and automated imaging for live-cell tracking under confinement.

## Key findings

- Planar confinement reduces cell area and cytoskeletal spread while altering cell cycle phase distributions.
- Confined conditions increase abnormal cell cycle events like prolonged G1 and mitotic slippage.
- Cell migration is faster during the G1 phase of the cell cycle under confinement.

## Abstract

Quantitative cell biology often examines migration and cell-cycle (CC) progression separately, limiting insights into their interplay under spatial constraints. Here, we present a vertically integrated platform combining multiplexed fluorescent reporters for CC phases, actin, and tubulin with photopatterned extracellular matrix islands of defined sizes, alongside an automated imaging pipeline (Fab2Mic) for high-throughput, live-cell tracking of migration and CC dynamics under planar confinement. Using HT1080 fibrosarcoma cells, we observed that planar confinement progressively reduced cell area and cytoskeletal spread, altered CC phase distributions, and increased abnormal CC events, including prolonged G1 and mitotic slippage, which is unique to confined conditions. Dynamic imaging revealed CC-dependent motility variations, with faster migration in G1. This system enables systematic, CC-aware mechanobiology studies under controlled confinement, providing access to dynamic phenotypes inaccessible to static assays and offering a scalable approach for mechanistic investigations and screening applications.

## Linked entities

- **Proteins:** ACTIN (hypothetical protein), gammaTub23C (gamma-Tubulin at 23C)

## Full-text entities

- **Genes:** HMGB2 (high mobility group box 2) [NCBI Gene 3148] {aka HMG2}, LAP (Laryngeal adductor paralysis) [NCBI Gene 7939], MMRN1 (multimerin 1) [NCBI Gene 22915] {aka ECM, EMILIN4, GPIa*, MMRN}, H3P16 (H3 histone pseudogene 16) [NCBI Gene 644914] {aka H3.6, H3F3AP6, p21}, GMNN (geminin DNA replication inhibitor) [NCBI Gene 51053] {aka Gem, MGORS6}, TUBA1B (tubulin alpha 1b) [NCBI Gene 10376] {aka K-ALPHA-1}, FN1 (fibronectin 1) [NCBI Gene 2335] {aka CIG, ED-B, FINC, FN, FNZ, GFND}, CFP (complement factor properdin) [NCBI Gene 5199] {aka BFD, PFC, PFD, PROPERDIN}, LOC106557476 (tubulin alpha-1A chain) [NCBI Gene 106557476] {aka TUBA1A}, MAP2K7 (mitogen-activated protein kinase kinase 7) [NCBI Gene 5609] {aka JNKK2, MAPKK7, MEK, MEK 7, MKK7, PRKMK7}, BRAF (B-Raf proto-oncogene, serine/threonine kinase) [NCBI Gene 673] {aka B-RAF1, B-raf, BRAF-1, BRAF1, NS7, RAFB1}, TUBA1B (tubulin, alpha 1b) [NCBI Gene 608864], EEF1A2 (eukaryotic translation elongation factor 1 alpha 2) [NCBI Gene 1917] {aka DEE33, EEF1AL, EF-1-alpha-2, EF1A, EIEE33, HS1}, HPRT1 (hypoxanthine phosphoribosyltransferase 1) [NCBI Gene 3251] {aka HGPRT, HPRT}, CDT1 (chromatin licensing and DNA replication factor 1) [NCBI Gene 81620] {aka DUP, RIS2}, DCTN6 (dynactin subunit 6) [NCBI Gene 10671] {aka WS-3, WS3, p27}
- **Diseases:** Long Mitosis (MESH:D000094024), deaths (MESH:D003643), cytotoxic (MESH:D064420), infection (MESH:D007239), CC (MESH:D000091622), melanoma (MESH:D008545), fibrosarcoma (MESH:D005354), cancer (MESH:D009369)
- **Chemicals:** polybrene (MESH:D006583), agarose (MESH:D012685), Dia (MESH:C076868), CO2 (MESH:D002245), DAPI (MESH:C007293), Cy5 (MESH:C085321), PBS (MESH:D007854), HEPES (MESH:D006531), penicillin (MESH:D010406), ozone (MESH:D010126), Apo (-), phenol red (MESH:D010637), nocodazole (MESH:D015739), Lipofectamine 2000 (MESH:C086724), TRIzol (MESH:C411644), water (MESH:D014867), Hygromycin B (MESH:D006921), Silicone oil (MESH:D012827), ethanol (MESH:D000431), NaOH (MESH:D012972), EdU (MESH:C031086), PI (MESH:D010716), hygromycin (MESH:C026273), streptomycin (MESH:D013307), FITC (MESH:D016650), EDTA (MESH:D004492), Taxol (MESH:D017239)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** HT1080 — Homo sapiens (Human), Fibrosarcoma, Cancer cell line (CVCL_0317), HEK293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), -1080 — Homo sapiens (Human), Transformed cell line (CVCL_7345)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12962752/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12962752/full.md

## References

76 references — full list in the complete paper: https://tomesphere.com/paper/PMC12962752/full.md

---
Source: https://tomesphere.com/paper/PMC12962752